The Eisai Assistance Program can provide information to patients and healthcare professionals about coverage for BELVIQ® or BELVIQ XR® and programs to help patients afford their medication. Depending on your financial situation and clinical status, resources may be available to help with your costs for BELVIQ®.
The Eisai Assistance Program can also provide information about the Patient Assistance Program for BELVIQ® which provides support to customers who need assistance paying for BELVIQ®. This program provides BELVIQ® at no cost to financially needy patients who meet program eligibility criteria. BELVIQ XR® is not available through the Patient Assistance Program at this time.
1. If your commercial insurance covers BELVIQ® or
BELVIQ XR®, simply use this program and pay as little as $40 on every 30 day supply.
2. If you are paying cash or your commercial insurance or Medicare Part D plan does not cover BELVIQ® or BELVIQ XR®, we can help! Use the card to Receive Up to $195 on every 30 day supply.
Get your savings card by clicking here. If you have any questions about the program rules or require additional information, please call
1-855-BELVIQ1 (tel: 1-855-235-8471) (8:00AM - 11:00 PM ET Monday - Friday)
* Savings Card is not available to patients who are eligible for state or federal health care programs. However, Medicare Part D beneficiaries whose coverage does not include BELVIQ® or BELVIQ XR® may use this card. See Complete Restrictions and Conditions of Use below.
For patients with commercial insurance that covers the product, the patient pays the first $40, and then Eisai will provide no more than $160 off the patient’s outof-pocket costs per commercially insured covered prescription. Patient could have additional costs based on coverage. For patients paying cash who have commercial insurance that does not cover the product, Medicare Part D, or are uninsured, Eisai will provide no more than $195 off the patient’s cash price per 30 day fill.
Good toward the purchase of prescriptions for BELVIQ® (lorcaserin HCI) CIV or BELVIQ XR® (lorcaserin HCI) CIV for up to 13 uses per year. Limited to 1 prescription per patient for any 30-day period. Must be 18 years of age or older.
Not available to individuals eligible for federal healthcare programs that may cover prescription drugs, including Medicaid, CHAMPVA, the Department of Veterans Affairs healthcare program, TRICARE, or the Puerto Rico Government Health Insurance Plan, or any similar state or federal healthcare programs.
Medicare Part D patients whose insurance does NOT cover BELVIQ® or BELVIQ XR® may use this card if paying the full cash price for a prescription covered by this card and no claim is submitted to Medicare, or any other federal, state, or other governmental program. Out-of-pocket expenses incurred using this card cannot be applied towards Medicare Part D true out-of-pocket (TrOOP) expenses.
Not valid for prescriptions for BELVIQ or BELVIQ XR reimbursed in full by any third party payer.
Patients and pharmacies are responsible for disclosing to insurance carriers the redemption and value of the card and complying with any other conditions imposed by insurance carriers, third-party payers, or applicable law.
May not be combined with any other coupon, discount, prescription savings card, free trial, or other offer.
The value of this card is not contingent on any prior or future purchases.
Void outside the USA, including US territories and where prohibited by law.
This card expires 12/31/2020.
Offer available to MA residents through July 1, 2019.
This card is not an insurance program.
This card may not be accepted at all pharmacies.
Federal law prohibits the selling, purchasing, trading, or counterfeiting of this savings card.
Eisai Inc. reserves the right to rescind, revoke, or amend this offer without notice at any time.
Other restrictions apply.
If you have any questions about the program rules or require additional information, please call 1-855-BELVIQ1 (1-855-235-8471).
Eisai has created the Assistance Program for BELVIQ® for eligible patients who need assistance paying for BELVIQ®. This program provides BELVIQ® at low cost to financially needy patients who meet program eligibility criteria. Patients can call the Patient Assistance Program for BELVIQ® at 1-866-61-EISAI (1-866-613-4724) to determine eligibility. The hours of operation are Monday through Friday, 8am to 8pm ET. BELVIQ XR® is not available through the Patient Assistance Program at this time.
Eisai reserves the right, at its sole discretion, to discontinue the Patient Assistance Program or change the qualifications at any time. All patient information remains confidential. Product supply for the program depends upon availability
Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record.
BELVIQ®/BELVIQ XR® is a FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some adults (Body Mass Index [BMI] ≥27 kg/m²) living with extra weight, with a weight-related medical problem, or adults living with obesity (BMI≥30 kg/m²), lose weight and keep it off.
It is not known if BELVIQ/BELVIQ XR when taken with other prescription, over-the-counter, or herbal weight-loss products is safe and effective. It is not known if BELVIQ/BELVIQ XR changes your risk of heart problems, stroke, or death due to heart problems or stroke.
BELVIQ®/BELVIQ XR® is a federally controlled substance (CIV) because they may be abused or lead to drug dependence.
For more information about BELVIQ®/BELVIQ XR® talk to your Healthcare Provider and see the full Product Information.
You are encouraged to report negative side effects of prescription drugs to the FDA.
The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.
This site is intended for residents of the United States only. Any products discussed herein may have different product labeling in different countries.
BELVIQ® and BELVIQ XR® are registered trademarks of Eisai Inc.